A Multi-Center, Open-Label, Surveillance Trial To Evaluate The Safety and Efficacy of a Shortened Infusion Time of Intravenous Ibuprofen
Phase of Trial: Phase IV
Latest Information Update: 04 Sep 2016
At a glance
- Drugs Ibuprofen (Primary)
- Indications Fever; Pain
- Focus Adverse reactions
- Sponsors Cumberland Pharmaceuticals
- 07 Jan 2015 Results published in Clinical Therapeutics.
- 21 Feb 2013 Top-line results have been reported in a Cumberland Pharmaceuticals media release.
- 19 Feb 2013 Status changed from recruiting to completed based on information reported in a Cumberland Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History